INS and metabolic syndrome: Clinical screening tools such as metabolic syndrome (7, 8), insulin sensitivity/resistance (9, 10), triglyceride-glucose index (11, 12) and other cardiovascular health indices (e.g. Framingham Risk score, FUSTER-BEWAT, ICHI) (6, 13) have already been suggested as robust indicators of cardiovascular disease risk in low risk populations.